Share of U.S. teenagers who had an HPV vaccination 2017, by poverty level

Percentage of adolescents in the U.S. aged 13 to 17 years who had received a human papillomavirus (HPV) vaccination as of 2017, by poverty level

Loading statistic...
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

August 2018

Region

United States

Survey time period

2017

Number of respondents

20,949 adolescents

Age group

13-17 years

Special properties

parents and guardians of adolescents

Method of interview

Telephone interview

Supplementary notes

HPV = human papillomavirus.
HPV vaccine, 9-valent (9vHPV), quadrivalent (4vHPV), or bivalent (2vHPV).
Adolescents were classified as below poverty level if their total family income was less than the federal poverty level specified for the applicable family size and number of children aged <18 years. All others were classified as at or above the poverty level.
* UTD = up-to-date. HPV UTD includes those with ≥3 doses and those with 2 doses when the first HPV vaccine dose was initiated at age <15 years and at least 5 months minus 4 days elapsed between the first and second dose. This update to the HPV recommendation occurred in December of 2016.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Statistics on " Vaccine-preventable diseases in the U.S. "

Other statistics that may interest you Vaccine-preventable diseases in the U.S.

Overview

7

Global disease incidence

8

Tuberculosis (BCG Immunization)

5

Influenza (HiB Immunization)

8

Measles Mumps and Rubella (MMR Immunization)

7

Diphtheria Tetanus and Pertussis (DTP3 Immunization)

8

Hepatitis A and B

7

Human Papilloma Virus (HPV Immunization)

7

Further related statistics

10
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Learn more about how Statista can support your business.